Occupational exposures and risk of systemic lupus erythematosus: A review of the evidence and exposure assessment methods in population-and clinic-based studies

Lupus

Volumn 15, Issue 11, 2006, Pages 728-736

  Parks, Christine G ^a   Cooper, G S ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PESTICIDE; SILICON DIOXIDE; SOLVENT;

ANIMAL; APOPTOSIS; CLINICAL TRIAL; DRUG EFFECT; EVIDENCE BASED MEDICINE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METHODOLOGY; OCCUPATIONAL EXPOSURE; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; APOPTOSIS; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNE SYSTEM; LUPUS ERYTHEMATOSUS, SYSTEMIC; OCCUPATIONAL EXPOSURE; PESTICIDES; RISK ASSESSMENT; RISK FACTORS; SILICON DIOXIDE; SOLVENTS;

EID: 34250652828     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306069346     Document Type: Review

References (68)

1. Cooper GS, Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep 2004; 6: 367-374.
2. Parks CG, Cooper GS. Occupational exposures and risk of systemic lupus erythematosus. Autoimmunity 2005; 38: 497-506.
3. Bramwell B. Diffuse scleroderma: Its frequency and occurrence in stonemasons; its treatment by fibrinolysin; Elevations of temperature due to fibrinolysin injections. Edinburg Med J 1914; 12: 387-387.
4. Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999; 107(Suppl 5): 793-802.
5. Brown LM, Gridley G, Olsen JH, Mellemkjaer L, Linet MS, Fraumeni JF Jr. Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J Occup Environ Med 1997; 39: 633-638.
6. Conrad K, Mehlhorn J, Luthke K, Dorner T, Frank KH. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus 1996; 5: 62-69.
7. Finch A, Cooper GS, Chibnik LB, Costenbader KH, Fraser PA, Karlson EW. Occupational exposures and risk of systemic lupus erythematosus. Arthritis and Rheumatism 2005; 52(Suppl): S733-S733.
8. Koeger AC, Lang T, Alcaix D, et al. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 1995; 74: 221-237.
9. Parks CG, Cooper GS, Nylander-French LA et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the southeastern United States. Arthritis Rheum 2002; 46: 1840-1850.
10. Rosenman KD, Moore-Fuller M, Reilly MJ. Connective tissue disease and silicosis. American Journal of Industrial Medicine 1999; 25: 375-381.
11. Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nunez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 1993; 52: 534-538.
12. Brown JM, Archer AJ, Pfau JC, Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 2003; 131: 415-421.
13. Pfau JC, Brown JM, Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004; 195: 167-176.
14. Brown JM, Pfau JC, Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol 2004; 16: 133-139.
15. Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A. Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol 2005; 289: L990-L998.
16. Friedetzky A, Garn H, Kirchner A, Gemsa D. Histopathological changes in enlarged thoracic lymph nodes during the development of silicosis in rats. Immunobiology 1998; 199: 119-132.
17. Huang SH, Hubbs AF, Stanley CF et al. Immunoglobulin responses to experimental silicosis. Toxicol Sci 2001; 59: 108-117.
18. Friedetzky A, Grau V, Wieckenberg M, Lewen A, Gemsa D, Garn H. Long term iNOS expression in thoracic lymph nodes of silicotic rats. Immunobiology 2002; 205: 219-230.
19. Garn H, Friedetzky A, Kirchner A, Jager R, Gemsa D. Experimental silicosis: A shift to a preferential IFN-gamma-based Th1 response in thoracic lymph nodes. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1221-L1230.
20. HIll AB. The environment and disease: Association or causation? Proc R Soc Med 1965; 58: 295-300.
21. Aryal BK, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 2001; 40: 271-274.
22. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 2004; 31: 1928-1933.
23. Gilbert KM, Griffin JM, Pumford NR. Trichloroethylene activates CD4+ T-cells: Potential role in an autoimmune response. Drug Metab Rev 1999; 31: 901-916.
24. Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 2000; 46: 123-137.
25. Griffin JM, Gilbert KM, Pumford NR. Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL +/+ mice. Toxicol Sci 2000; 54: 384-389.
26. Blossom SJ, Pumford NR, Gilbert KM. Activation and attenuation of apoptosis of CD4 T-cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid. J Autoimmun 2004; 23: 211-220.
27. Ward E, Hornung R, Morris J et al. Risk of low red or white blood cell count related to estimated benzene exposure in a rubberworker cohort (1940-1975). Am J Ind Med 1996; 29: 247-257.
28. Balluz L, Philen R, Ortega L et al. Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 2001; 154: 1029-1036.
29. Cooper GS, Miller FW, Germolec DR. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002; 2: 303-313.
30. Sobel ES, Gianini J, Butfiloski EJ, Croker BP, Schiffenbauer J, Roberts SM. Acceleration of autoimmunity by organochlorine pesticides in (NZB NZW)F1 mice. Environ Health Perspect 2005; 113: 323-328.
31. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study. Arthritis Rheum 2002; 46: 1830-1939.
32. Bigazzi PE. Metals and kidney autoimmunity. Environ Health Perspect 1999; 107(Suppl 5): 753-765.
33. Leffel EK, Wolf C, Poklis A, White KL Jr. Drinking water exposure to cadmium, an environmental contaminant, results in the exacerbation of autoimmune disease in the murine model. Toxicology 2003; 188: 233-250.
34. Hudson CA, Cao L, Kasten-Jolly J, Kirkwood JN, Lawrence DA. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J Toxicol Environ Health A 2003; 66: 895-918.
35. Rowley B, Monestier M. Mechanisms of heavy metal-induced autoimmunity. Mol Immunol 2005; 42: 833-838.
36. Hasan T, Pertovaara M, Yli-Kerttula U, Luukkaala T, Korpela M. Seasonal variation of disease activity of systemic lupus erythematosus in Finland: A 1 year follow up study. Ann Rheum Dis 2004; 63: 1498-1500.
37. Meller S, Winterberg F, Gilliet M et al. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005; 52: 1504-1516.
38. Angotti C. Immunology of cutaneous lupus erythematosus. Clin Dermatol 2004; 22: 105-112.
39. Fraser PA, Ding WZ, Mohseni M et al. Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: A possible gene-environment interaction for autoimmunity. J Rheumatol 2003; 30: 276-282.
40. Vaisberg MW, Kaneno R, Franco MF, Mendes NF. Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZB W) mice. J Clin Lab Anal 2000; 14: 91-96.
41. Caricchio R, McPhie L, Cohen PL. Ultraviolet B radiation-induced cell death: Critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol 2003; 171: 5778-5786.
42. Pawlak CR, Witte T, Heiken H et al. Flares in patients with systemic lupus erythematosus are associated with daily psychological stress. Psychother Psychosom 2003; 72: 159-165.
43. Herrmann M, Scholmerich J, Straub RH. Stress and rheumatic diseases. Rheum Dis Clin North Am 2000; 26: 737-763, viii-viii.
44. Jacobs R, Pawlak CR, Mikeska E et al. Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology (Oxford) 2001; 40: 868-875.
45. Pawlak CR, Jacobs R, Mikeska E et al. Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress. Brain Behav Immun 1999; 13: 287-302.
46. Belkic KL, Landsbergis PA, Schnall PL, Baker D. Is job strain a major source of cardiovascular disease risk? Scand J Work Environ Health 2004; 30: 85-128.
47. Mohr DC, Pelletier D. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 2006; 20: 27-36.
48. Toker S, Shirom A, Shapira I, Berliner S, Melamed S. The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol 2005; 10: 344-362.
49. Jeanmonod P, von Kanel R, Maly FE, Fischer JE. Elevated Plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha-308 G/A polymorphism. Psychosom Med 2004; 66: 501-506.
50. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
51. Conrad K, Mehlhorn J. Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int Arch Allergy Immunol 2000; 123: 77-91.
52. Subra JF, Renier G, Reboul P et al. Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol 2001; 126: 540-544.
53. Rosenberg AM, Semchuk KM, McDuffie HH et al. Prevalence of anti-nuclear antibodies in a rural population. J Toxicol Environ Health A 1999; 57: 225-236.
54. Cooper GS, Martin SA, Longnecker MP, Sandler DP, Germolec DR. Associations between plasma DDE levels and immunologic measures in African-American farmers in North Carolina. Environ Health Perspect 2004; 112: 1080-1084.
55. Cooper GS, Parks CG, Schur PS, Fraser PA. Occupational and environ-mental associations with antinuclear antibodies in a general population sample. J Environ Toxicol 2006; (in press).
56. Parks CG, Cooper GS, Nylander-French LA, Hoppin JA, Sanderson WT, Dement JM. Comparing questionnaire-based methods to assess occupational silica exposure. Epidemiology 2004; 15: 433-441.
57. Stewart WF, Correa-Villasenor A. False positive exposure errors and low exposure prevalence in community-based case-control studies. Applied Occupational and Industrial Hygiene 1991; 6: 534-540.
58. Stewart PA, Stewart WF, Heineman EF, Dosemeci M, Linet M, Inskip PD. A novel approach to data collection in a case-control study of cancer and occupational exposures. Int J Epidemiol 1996; 25: 744-752.
59. Rothman KJ, Greenland S. Modern epidemiology. Lippincott-Raven, 1998.
60. Teschke K, Smith JC, Olshan AF. Evidence of recall bias in vidunteered vs. prompted responses about occupational exposures. Am J Ind Med 2000; 38: 385-388.
61. Stewart PA, Stewart WF, Siemiatycki J, Heineman EF, Dosemeci M. Questionnaires for collecting detailed occupational information for community-based case control studies. Am Ind Hyg Assoc J 1998; 59: 39-44.
62. Hepworth SJ, Bolton A, Parslow RC, van Tongeren M, Muir KR, McKinney PA. Assigning exposure to pesticides and solvents from self-reports collected by a computer assisted personal interview and expert assessment of job codes: The UK Adult Brain Tumour Study. Occup Environ Med 2006; 63: 267-272.
63. Teschke K, Olshan AF, Daniels JL et al. Occupational exposure assessment in case-control studies: Opportunities for improvement. Occup Environ Med 2002; 59: 575-594.
64. Siemiatycki J, Dewar R, Richardson L. Costs and statistical power associated with five methods of collecting occupation exposure information for population-based case-control studies. Am J Epidemiol 1989; 130: 1236-1246.
65. Gueguen A, Goldberg M, Bonenfant S, Martin JC. Using a representative sample of workers for constructing the SUMEX French general population based job-exposure matrix. Occup Environ Med 2004; 61: 586-593.
66. Kauppinen T, Toikkanen J, Pukkala E. From cross-tabulations to multi-purpose exposure information systems: A new job-exposure matrix. Am J Ind Med 1998; 33: 409-417.
67. Yucesoy B, Vallyathan V, Landsittel DP, Simeonova P, Luster MI. Cytokine polymorphisms in silicosis and other pneumoconioses. Mol Cell Biochem 2002; 234-235: 219-224.
68. Stolt P, Kallberg H, Lundberg I, Sjogren B, Klareskog L, Alfredsson L. Silica exposure is associated with increased risk of developing rheumatoid arthritis: Results from the Swedish EIRA study. Ann Rheum Dis 2005; 64: 582-586.